Fighting Addiction TogetherFighting Addiction TogetherWe Do Recover
Opinion

Kratom, 7-OH, and the Money in Washington: What 60 Minutes Found—and What Families Deserve to Know

Kratom, concentrated 7-OH, lobbying and federal policy: what the reporting says, what remains disputed and what families should know.

Reviewed 17 November 2026. Reporting and commentary. Political claims are attributed to CBS; health and policy sources are linked below.

A bottle that says plant-based. A tablet sold at the gas station. A promise of energy, calm, or relief.

None of those things tells you whether a product can lead to dependence. And the fact that something sits on a store shelf does not mean it is safe.

I know addiction from the inside. I know how easily something that starts as an answer to a problem can become a problem of its own. That's why the November 15, 2026, 60 Minutes investigation into kratom, concentrated 7-OH, and the lobbying fight in Washington deserves more than a headline and a political argument.

It deserves to be understood—especially by the people taking these products and the families who love them.

The people behind the headlines

The 60 Minutes report followed Melanie Clark, a Michigan mother who said she tried a kratom-containing drink called Feel Free because she wanted more energy. Within weeks, she told CBS, she felt dependent on it. Later, after stopping the drink, she said she began using concentrated 7-OH tablets made by a different company and experienced a severe crisis that led to hospitalization.

That distinction matters: a kratom drink and concentrated 7-OH tablets are not the same product. We should not blur them together to make a more dramatic story.

CBS also spoke with parents who had lost sons and were asking why products their families had believed were relatively harmless remained so widely available. In some of the deaths discussed, medical findings named mitragynine, a major compound in kratom, alongside other medications; in others, CBS reported mitragynine alone.

These families are not a political talking point. Their questions deserve serious answers.

Kratom and concentrated 7-OH: what's the difference?

Kratom comes from a Southeast Asian tree. Its leaves contain compounds including mitragynine, which acts on opioid receptors. The plant naturally contains only small amounts of 7-hydroxymitragynine, usually called 7-OH.

Products with added, enhanced, or concentrated 7-OH are a different concern. They can be sold as tablets, gummies, shots, or mixes. The FDA warns that enhanced 7-OH products can cause serious harm, including dependence, withdrawal, and seizures. The FDA says there are no FDA-approved 7-OH products for any medical use, including treating opioid withdrawal.

That does not mean ordinary botanical kratom is automatically safe. The FDA also warns about serious risks associated with kratom itself, including substance use disorder. Nor does it mean that everyone who uses kratom will have the same experience. We need accurate distinctions, not scare tactics or blanket promises.

The money trail—and what it does not prove

One of the most troubling parts of the 60 Minutes investigation was not a laboratory finding. It was the money and influence surrounding federal policy.

CBS reported that public filings show millions of dollars spent on lobbying over the past decade, including spending by the American Kratom Association aimed at federal agencies and lawmakers. CBS also reported that Botanic Tonics, the maker of Feel Free, and founder J.W. Ross contributed nearly $1.2 million to political campaigns associated with Robert F. Kennedy Jr. and the Make America Healthy Again PAC.

The report said Markwayne Mullin disclosed an investment in Botanic Tonics of up to $1 million; he confirmed the investment and denied lobbying. CBS said it sought a response from Botanic Tonics without receiving one.

Former HHS adviser Calley Means and former FDA commissioner Marty Makary told CBS they believed business interests had shaped recent kratom policy. HHS denied to CBS that political contributions or outside pressure influenced its recommendation. Its October 9 announcement separately described the recommendation as based on updated scientific analysis. The American Kratom Association emphasized a distinction between botanical kratom and chemically enhanced products.

Here's the line we must not cross: CBS reported lobbying and campaign contributions; those facts alone do not establish that anyone bought a government decision. We can demand transparency without claiming an unproven crime.

What actually changed in federal 7-OH policy?

In October 2026, HHS recommended a new approach for deciding which 7-OH and related products would fall under proposed federal Schedule I controls. The Department of Justice announced that the DEA was issuing revised notices of intent designed to distinguish trace amounts associated with botanical kratom from concentrated or enhanced products.

CBS described the revised threshold as 20 times higher than the earlier proposal. But this is the critical detail often lost in headlines: that figure concerns a proposed scheduling threshold, not a safe dose, a government product approval, or a blanket permission to sell 7-OH. The Justice Department's October announcement and the FDA's consumer warning make the regulatory and safety issues separate.

A notice of intent is not the same as an effective scheduling order. In addition, federal scheduling rules, FDA restrictions, and individual state laws are different layers of regulation. Check the current law before making any legal-status claim; this article is not a real-time legal tracker.

What I'd tell somebody in recovery

I don't care which political party somebody belongs to. If a product can create dependence, people deserve honest labeling and honest information. If a family has lost somebody, they deserve to be heard. And if public policy is being shaped while businesses spend millions to influence it, the public deserves to see the evidence and ask hard questions.

But I also don't want anyone reading this to feel judged. People reach for relief because they are hurting, exhausted, afraid, or trying to get through another day. I understand that. What matters now is what we do with the truth.

If you're using kratom or 7-OH regularly and you're worried you've become dependent, tell a healthcare professional exactly what product you use, how often, and whether you take anything else. Bring the packaging if you can. Withdrawal and other complications deserve individual medical guidance, not random dosing advice online.

For a suspected poisoning or harmful reaction, call Poison Help at 1-800-222-1222. If someone is unresponsive or in immediate danger, call 911.

This is why Fighting Addiction Together exists

Getting off a substance is only the beginning. After that comes the work of learning to live without the thing we once believed was our solution.

That's why I believe in H.E.A.L. — Helping Everyone Achieve Life. The point isn't simply to survive the next day. It's to build a life we don't have to escape from—and to help the next person build one too.

We need reporting that follows the money, science that stands up to scrutiny, and communities that refuse to abandon people when the headlines move on.

No shame. No sales pitch. Just the truth, the support, and the belief that recovery is possible.

Together, WE Can and WE Do Recover.


Sources and further reading

Fighting Addiction Together is a peer recovery community, not a treatment center. This article is educational and does not substitute for individual medical or legal advice. Policy developments described above are dated historical announcements, not a statement of today’s legal status.